Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis (2022)

Peer-Reviewed Study · Zhang H; Xu X; Xu R; Ye T; et al. · 2022

Zhang H et al., 2022: Mouse melanoma study showing ivermectin blocks neutrophil extracellular trap formation and suppresses orthotopic B16F10 lung metastasis, while having no effect on primary tumour growth.

In vivo, IVM treatment showed no effects of melanoma tumor growth, while the orthotopic melanoma to lung metastasis was significantly suppressed by IVM.

n/a (HTML full text)

Zhang H et al., 2022: Mouse melanoma study showing ivermectin blocks neutrophil extracellular trap formation and suppresses orthotopic B16F10 lung metastasis, while having no effect on primary tumour growth. Study type: B16F10 mouse melanoma, subcutaneous and orthotopic metastasis models; also a 231-compound screen and neutrophil assays. N: 3 groups (control, vehicle NaCMC, ivermectin). Country: China (Fudan University, Shanghai). Dose: 10 mg/kg orally every other day for 14 days; comparator: NaCMC vehicle. Declared COI: none declared. IMPORTANT LIMITING RESULT recorded verbatim: no effect on primary melanoma growth. Also relevant to C10. Study type: animal.